Ludovic Doucet
Institut de Cancérologie de l'Ouest(FR)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, vaccines and immunoinformatics approaches, Cancer Genomics and Diagnostics
Most-Cited Works
- → 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer(2019)641 cited
- → 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19(2022)412 cited
- → Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma(2020)134 cited
- → Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis(2016)74 cited
- → KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation.(2024)68 cited
- → Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease(2018)68 cited
- → A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors(2019)61 cited
- → MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels(2017)59 cited
- → One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective study(2020)45 cited
- → Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study(2022)40 cited